IVO

The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells

Ovarian cancer is the most lethal gynecological cancer in the [...]

Breakthroughs In Gene Editing Allow For The Creation Of Superior Preclinical Oncology Models

Gene editing is getting a lot of attention in the [...]

Title